![Jon Congleton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon Congleton
Chief Executive Officer at
MINERALYS THERAPEUTICS, INC.
Net worth: 19 M $ as of 30/05/2026
Profile
Jon Congleton is currently President, Chief Executive Officer & Director at Mineralys Therapeutics, Inc. since 2020.
Mr. Congleton is also an Independent Director at Immunic, Inc. and Avalyn Pharma, Inc., both starting in 2026.
Additionally, Mr. Congleton serves as Operating Partner at Catalys Pacific LLC.
Former roles include President & Chief Executive Officer at Alpine Immune Sciences, Inc., President, Chief Executive Officer & Director at IPI Legacy Liquidation Co. from 2017 to 2020, President, Chief Executive Officer & Director at Nivalis Therapeutics, Inc. from 2014 to 2017, Vice President & General Manager at Teva Neuroscience, Inc., and Senior VP-Global Central Nervous System Disorders at Teva Pharmaceutical Industries Ltd. from 2013 to 2014.
Education includes undergraduate studies at Kansas State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2026 | 614,321 ( 0.81% ) | 19 M $ | 30/05/2026 | |
AVALYN PHARMA INC -.--% | 28/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Jon Congleton active positions
| Companies | Position | Start |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Chief Executive Officer | 31/10/2020 |
| IMMUNIC, INC. | Director/Board Member | 26/03/2026 |
| AVALYN PHARMA INC. | Director/Board Member | 31/03/2026 |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific invests in companies located in Cayman Islands. The firm targets companies operating in the fields of health services and health technology. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Former positions of Jon Congleton
| Companies | Position | End |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Chief Executive Officer | 04/05/2020 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Chief Executive Officer | 14/01/2017 |
| ALPINE IMMUNE SCIENCES, INC. | Chief Executive Officer | 31/12/2016 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Sales & Marketing | 30/11/2014 |
Teva Neuroscience, Inc.
 Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for neurological disorders | Corporate Officer/Principal | - |
Training of Jon Congleton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
Kansas State University
 Kansas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Neuroscience, Inc.
Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for neurological disorders | Health Technology |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific invests in companies located in Cayman Islands. The firm targets companies operating in the fields of health services and health technology. It provides financing for early stage capital requirements. | Finance |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
- Stock Market
- Insiders
- Jon Congleton
Choose MarketScreener 
